Bourgeon Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Bourgeon Capital Management's LLY Position: Q3 2026 in Review
Bourgeon Capital Management reduced its Eli Lilly (LLY) stake by 0.64% in Q3 2026, selling an estimated $184K and leaving 24,270 shares worth $28.1M. The position accounts for 4.03% of the portfolio, ranked #3.
Bourgeon Capital Management first reported a position in LLY in Q3 2020 and has held it in 9 quarters since. The position peaked at $29.3M in Q2 2026. 4,626 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Bourgeon Capital Management held 24,270 shares of Eli Lilly worth $28.1M as of Q3 2026.
- Bourgeon Capital Management sold 156 Eli Lilly shares in Q3 2026, an estimated $184K.
- Eli Lilly made up 4.03% of Bourgeon Capital Management's portfolio in Q3 2026, its #3 holding.
- Bourgeon Capital Management first reported a position in Eli Lilly in Q3 2020 and has held it in 9 quarters since.
- Bourgeon Capital Management's Eli Lilly position peaked at $29.3M in Q2 2026.
- 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Bourgeon Capital Management's 13F filing for Q3 2026, filed 19 Oct 2026.